BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savarino E, Marabotto E, Zentilin P, Frazzoni M, Sammito G, Bonfanti D, Sconfienza L, Assandri L, Gemignani L, Malesci A. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011;43:542-547. [PMID: 21376679 DOI: 10.1016/j.dld.2011.01.016] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Visaggi P, Mariani L, Svizzero FB, Tarducci L, Sostilio A, Frazzoni M, Tolone S, Penagini R, Frazzoni L, Ceccarelli L, Savarino V, Bellini M, Gyawali PC, Savarino EV, de Bortoli N. Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease. Esophagus 2022. [PMID: 35768671 DOI: 10.1007/s10388-022-00933-6] [Reference Citation Analysis]
2 Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV, Mekhtiev SN, Mekhtieva OA, Metsaeva ZV, Petelin DS, Simanenkov VI, Sitkin SI, Cheremushkin SV, Chernogorova MV, Khavkin АI. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-5-117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:453-81. [PMID: 34642267 DOI: 10.5056/jnm21077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
4 DeLay K, Pandolfino JE, Roman S, Gyawali CP, Savarino E, Tye M, Kaizer A, Yadlapati R. Diagnostic yield and reliability of post-prandial high-resolution manometry and impedance-ph for detecting rumination and supragastric belching in PPI non-responders. Neurogastroenterol Motil 2021;:e14106. [PMID: 33687131 DOI: 10.1111/nmo.14106] [Reference Citation Analysis]
5 Kim SY, Jung H, Lee HA. Normal acid exposure time in esophageal pH monitoring in Asian and Western populations: A systematic review and meta‐analysis. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Fabisiak A, Bartoszek A, Talar M, Binienda A, Dziedziczak K, Krajewska JB, Mosińska P, Niewinna K, Tarasiuk A, Mokrowiecka A, Wierzchniewska-Ławska A, Małecka-Panas E, Salaga M, Fichna J. Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. J Clin Med 2020;9:E4111. [PMID: 33419235 DOI: 10.3390/jcm9124111] [Reference Citation Analysis]
7 Marabotto E, Savarino E, de Bortoli N, Giannini EG. Refractoriness to Treatment Suggests That Clinical Evaluation Should Go Beyond the Diagnosis of Reflux Disease. Clin Gastroenterol Hepatol 2021;19:1077-8. [PMID: 33248089 DOI: 10.1016/j.cgh.2020.06.057] [Reference Citation Analysis]
8 Savarino V, Marabotto E, Zentilin P, Demarzo MG, Pellegatta G, Frazzoni M, De Bortoli N, Tolone S, Giannini EG, Savarino E. Esophageal reflux hypersensitivity: Non-GERD or still GERD? Dig Liver Dis 2020;52:1413-20. [PMID: 33097427 DOI: 10.1016/j.dld.2020.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gyawali CP, Carlson DA, Chen JW, Patel A, Wong RJ, Yadlapati RH. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol 2020;115:1412-28. [PMID: 32769426 DOI: 10.14309/ajg.0000000000000734] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
10 Zhang MY, Tan ND, Li YW, Sifrim D, Pandolfino JE, Xiao YL, Chen MH. Esophageal symptoms versus epigastric symptoms: Relevance for diagnosis of gastroesophageal reflux disease. J Dig Dis 2020;21:696-704. [PMID: 32975045 DOI: 10.1111/1751-2980.12946] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Savarino E, Frazzoni M, Marabotto E, Zentilin P, Iovino P, Costantini M, Tolone S, Battaglia E, Cicala M, Usai-satta P, de Bortoli N, Penagini R, Savarino V. A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring. Digestive and Liver Disease 2020;52:966-80. [DOI: 10.1016/j.dld.2020.04.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
12 Talley NJ, Zand Irani M. Optimal management of severe symptomatic gastroesophageal reflux disease. J Intern Med 2021;289:162-78. [PMID: 32691466 DOI: 10.1111/joim.13148] [Reference Citation Analysis]
13 Aggarwal P, Kamal AN. Reflux Hypersensitivity: How to Approach Diagnosis and Management. Curr Gastroenterol Rep 2020;22:42. [PMID: 32651667 DOI: 10.1007/s11894-020-00779-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu PI, Sloan JA, Kuribayashi S, Gregersen H. Impedance in the evaluation of the esophagus. Ann N Y Acad Sci 2020;1481:139-53. [PMID: 32557676 DOI: 10.1111/nyas.14408] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Horton AJ, Clayton SB. Optimization of impedance-measured reflux events in GORD utilizing acid exposure time. BMC Gastroenterol 2020;20:179. [PMID: 32517709 DOI: 10.1186/s12876-020-01321-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Fass R, Zerbib F, Gyawali CP. AGA Clinical Practice Update on Functional Heartburn: Expert Review. Gastroenterology 2020;158:2286-93. [DOI: 10.1053/j.gastro.2020.01.034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 2019;15:1081-93. [PMID: 31564886 DOI: 10.2147/TCRM.S184291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ghisa M, Della Coletta M, Barbuscio I, Marabotto E, Barberio B, Frazzoni M, De Bortoli N, Zentilin P, Tolone S, Ottonello A, Lorenzon G, Savarino V, Savarino E. Updates in the field of non-esophageal gastroesophageal reflux disorder. Expert Rev Gastroenterol Hepatol 2019;13:827-38. [PMID: 31322443 DOI: 10.1080/17474124.2019.1645593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
19 de Bortoli N, Chio TD, Mariani L, Savarino EV. Authors' reply. Ann Gastroenterol 2019;32:319. [PMID: 31040634 DOI: 10.20524/aog.2019.0369] [Reference Citation Analysis]
20 Chatila AT, Nguyen MTT, Krill T, Roark R, Bilal M, Reep G. Natural history, pathophysiology and evaluation of gastroesophageal reflux disease. Dis Mon 2020;66:100848. [PMID: 30803725 DOI: 10.1016/j.disamonth.2019.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
21 Naik RD, Evers L, Vaezi MF. Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease. Curr Treat Options Gastro 2019;17:1-17. [DOI: 10.1007/s11938-019-00213-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cesario S, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Diagnosis of GERD in typical and atypical manifestations. Acta Biomed 2018;89:33-9. [PMID: 30561415 DOI: 10.23750/abm.v89i8-S.7963] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Forootan M, Zojaji H, Ehsani MJ, Darvishi M. Advances in the Diagnosis of GERD Using the Esophageal pH Monitoring, Gastro-Esophageal Impedance-pH Monitoring, And Pitfalls. Open Access Maced J Med Sci 2018;6:1934-40. [PMID: 30455777 DOI: 10.3889/oamjms.2018.410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Norder Grusell E, Mjörnheim A, Finizia C, Ruth M, Bergquist H. The diagnostic value of GerdQ in subjects with atypical symptoms of gastro-esophageal reflux disease. Scandinavian Journal of Gastroenterology 2018;53:1165-70. [DOI: 10.1080/00365521.2018.1503708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
25 de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
26 Gharib A, Forootan M, Sharifzadeh M, Abdi S, Darvishi M, Eghbali A. Diagnostic Efficacy of 24-hr Esophageal pH Monitoring in Patients with Refractory Gastroesophageal Reflux Disease. Open Access Maced J Med Sci 2018;6:1235-8. [PMID: 30087727 DOI: 10.3889/oamjms.2018.268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Hobbs P, Gyawali CP. The role of esophageal pH-impedance testing in clinical practice. Current Opinion in Gastroenterology 2018;34:249-57. [DOI: 10.1097/mog.0000000000000441] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018;67:1351-62. [PMID: 29437910 DOI: 10.1136/gutjnl-2017-314722] [Cited by in Crossref: 542] [Cited by in F6Publishing: 384] [Article Influence: 135.5] [Reference Citation Analysis]
29 Lee YY, Wu JC. Management of Patients With Functional Heartburn. Gastroenterology 2018;154:2018-2021.e1. [DOI: 10.1053/j.gastro.2018.04.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Chi ZC. Reflux hypersensitivity. Shijie Huaren Xiaohua Zazhi 2018; 26(15): 885-891 [DOI: 10.11569/wcjd.v26.i15.885] [Reference Citation Analysis]
31 Gyawali CP, Azagury DE, Chan WW, Chandramohan SM, Clarke JO, Bortoli N, Figueredo E, Fox M, Jodorkovsky D, Lazarescu A, Malfertheiner P, Martinek J, Murayama KM, Penagini R, Savarino E, Shetler KP, Stein E, Tatum RP, Wu J. Nonerosive reflux disease: clinical concepts. Ann N Y Acad Sci 2018;1434:290-303. [DOI: 10.1111/nyas.13845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
32 Gyawali CP, Bortoli N, Clarke J, Marinelli C, Tolone S, Roman S, Savarino E. Indications and interpretation of esophageal function testing. Ann N Y Acad Sci 2018;1434:239-53. [DOI: 10.1111/nyas.13709] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
33 Guo MZ, Meng LN. Refractory gastroesophageal reflux disease: Current status and perspectives. Shijie Huaren Xiaohua Zazhi 2017; 25(33): 2921-2928 [DOI: 10.11569/wcjd.v25.i33.2921] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Yamasaki T, Fass R. Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil 2017;23:495-503. [PMID: 28992673 DOI: 10.5056/jnm17097] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
35 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
36 Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Martinucci I, Fuccio L, Savarino V, Savarino E. Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum. Ann Gastroenterol 2018;31:1-7. [PMID: 29333061 DOI: 10.20524/aog.2017.0199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
37 Zhang M, Chen M, Peng S, Xiao Y. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. United European Gastroenterol J 2018;6:358-66. [PMID: 29774149 DOI: 10.1177/2050640617735084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
38 Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP; International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol 2017;14:665-76. [PMID: 28951582 DOI: 10.1038/nrgastro.2017.130] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 23.2] [Reference Citation Analysis]
39 Savarino E, Zentilin P, Marabotto E, Pellegatta G, Coppo C, Brunacci M, Dulbecco P, Savarino V. Drugs for improving esophageal mucosa defense: where are we now and where are we going? Ann Gastroenterol 2017;30:585-91. [PMID: 29118552 DOI: 10.20524/aog.2017.0187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
41 Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:302-318. [PMID: 28827081 DOI: 10.1053/j.gastro.2017.07.049] [Cited by in Crossref: 109] [Cited by in F6Publishing: 75] [Article Influence: 21.8] [Reference Citation Analysis]
42 Vaezi MF, Sifrim D. Assessing Old and New Diagnostic Tests for Gastroesophageal Reflux Disease. Gastroenterology 2018;154:289-301. [PMID: 28774844 DOI: 10.1053/j.gastro.2017.07.040] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
43 Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017;62:1881-1889. [PMID: 28550489 DOI: 10.1007/s10620-017-4625-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
44 Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, Bertani H, Marchi S, Conigliaro R, Fuccio L, Savarino V, Savarino E. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017;29. [PMID: 28543861 DOI: 10.1111/nmo.13116] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
45 Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. [PMID: 28274109 DOI: 10.5056/jnm16214] [Cited by in Crossref: 297] [Cited by in F6Publishing: 227] [Article Influence: 59.4] [Reference Citation Analysis]
46 Tenca A, de Bortoli N, Mauro A, Frazzoni M, Savarino E, Massironi S, Russo S, Bertani L, Marchi S, Penagini R. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. Dig Liver Dis 2017;49:978-83. [PMID: 28487082 DOI: 10.1016/j.dld.2017.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
47 Chu C, Du Q, Li C, Zhang L, Zhou X, Zuo F, Zhang Y, Li F, Xie G, Li Y. Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn. PLoS One 2017;12:e0175263. [PMID: 28384225 DOI: 10.1371/journal.pone.0175263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, Vela M, Tutuian R, Tatum R, Sifrim D, Keller J, Fox M, Pandolfino JE, Bredenoord AJ; GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil 2017;29:1-15. [PMID: 28370768 DOI: 10.1111/nmo.13067] [Cited by in Crossref: 158] [Cited by in F6Publishing: 119] [Article Influence: 31.6] [Reference Citation Analysis]
49 Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther 2017;45:631-42. [PMID: 28116754 DOI: 10.1111/apt.13914] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
50 Savarino E, Ottonello A, Tolone S, Bartolo O, Baeg MK, Farjah F, Kuribayashi S, Shetler KP, Lottrup C, Stein E. Novel insights into esophageal diagnostic procedures. Ann N Y Acad Sci 2016;1380:162-77. [PMID: 27681220 DOI: 10.1111/nyas.13255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M, Bodini G, Russo S, Bertani L, Natali V, Fuccio L, Savarino V, Blandizzi C, Marchi S. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol 2016;111:1711-7. [PMID: 27644732 DOI: 10.1038/ajg.2016.432] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
52 Savarino E, Ottonello A, Martinucci I, Dulbecco P, Savarino V. Ilaprazole for the treatment of gastro-esophageal reflux. Expert Opinion on Pharmacotherapy 2016;17:2107-13. [DOI: 10.1080/14656566.2016.1232389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
53 de Bortoli N, Ottonello A, Zerbib F, Sifrim D, Gyawali CP, Savarino E. Between GERD and NERD: the relevance of weakly acidic reflux: Weakly acidic reflux in GERD. Ann N Y Acad Sci 2016;1380:218-29. [DOI: 10.1111/nyas.13169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
54 Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Current treatment options for esophageal diseases. Ann N Y Acad Sci 2016;1381:139-51. [PMID: 27391867 DOI: 10.1111/nyas.13146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
55 Savarino E, de Bortoli N, Bellini M, Galeazzi F, Ribolsi M, Salvador R, Savarino V, Penagini R. Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement. Dig Liver Dis 2016;48:1124-35. [PMID: 27443492 DOI: 10.1016/j.dld.2016.06.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
56 Luo X, Guo XX, Wang WF, Peng LH, Yang YS, Uedo N. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. World J Gastroenterol 2016; 22(14): 3845-3851 [PMID: 27076770 DOI: 10.3748/wjg.v22.i14.3845] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Patel A, Sayuk GS, Gyawali CP. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. Neurogastroenterol Motil 2016;28:1382-90. [PMID: 27061427 DOI: 10.1111/nmo.12838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
58 de Bortoli N, Martinucci I, Bertani L, Russo S, Franchi R, Furnari M, Tolone S, Bodini G, Bolognesi V, Bellini M, Savarino V, Marchi S, Savarino EV. Esophageal testing: What we have so far. World J Gastrointest Pathophysiol 2016; 7(1): 72-85 [PMID: 26909230 DOI: 10.4291/wjgp.v7.i1.72] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
59 Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, Mirante VG, Bertani H, Marchi S, Conigliaro R, Savarino V. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease. Clinical Gastroenterology and Hepatology 2016;14:40-6. [DOI: 10.1016/j.cgh.2015.06.026] [Cited by in Crossref: 163] [Cited by in F6Publishing: 134] [Article Influence: 27.2] [Reference Citation Analysis]
60 Patel A, Sayuk GS, Kushnir VM, Chan WW, Gyawali CP. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil. 2016;28:513-521. [PMID: 26686239 DOI: 10.1111/nmo.12745] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
61 de Bortoli N, Furnari M, Tolone S, Savarino E. A More In-depth Evaluation of Impedance-pH Could Assist in Distinguishing Reflux-related From Reflux-unrelated Heartburn. J Neurogastroenterol Motil 2015;21:621-2. [PMID: 26351254 DOI: 10.5056/jnm15085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Tolone S, De Bortoli N, Marabotto E, de Cassan C, Bodini G, Roman S, Furnari M, Savarino V, Docimo L, Savarino E. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterol Motil. 2015;27:1423-1431. [PMID: 26227513 DOI: 10.1111/nmo.12638] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
63 Pugliese D, Mauro A, Consonni D, Bravi I, Tenca A, Elvevi A, Conte D, Penagini R. pH Impedance vs. traditional pH monitoring in clinical practice: an outcome study. J Gastroenterol 2016;51:130-7. [DOI: 10.1007/s00535-015-1090-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
64 Tolone S, de Cassan C, de Bortoli N, Roman S, Galeazzi F, Salvador R, Marabotto E, Furnari M, Zentilin P, Marchi S, Bardini R, Sturniolo GC, Savarino V, Savarino E. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD. Neurogastroenterol Motil. 2015;27:1175-1182. [PMID: 26010058 DOI: 10.1111/nmo.12606] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
65 de Bortoli N, Martinucci I, Savarino E, Tutuian R, Frazzoni M, Piaggi P, Bertani L, Furnari M, Franchi R, Russo S, Bellini M, Savarino V, Marchi S. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082-8.e1. [PMID: 25499991 DOI: 10.1016/j.cgh.2014.11.035] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 11.6] [Reference Citation Analysis]
66 Cheng FK, Albert DM, Maydonovitch CL, Wong RK, Moawad FJ. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy. Clin Gastroenterol Hepatol 2015;13:867-73. [PMID: 25445765 DOI: 10.1016/j.cgh.2014.10.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
67 de Bortoli N, Martinucci I, Savarino E, Franchi R, Bertani L, Russo S, Ceccarelli L, Costa F, Bellini M, Blandizzi C. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure. Dis Esophagus. 2014;Epub ahead of print. [PMID: 25212408 DOI: 10.1111/dote.12284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Savarino E, Marabotto E, Bartolo O, de Cassan C. Comment on "impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602]. Dig Liver Dis 2014;46:1052. [PMID: 25081845 DOI: 10.1016/j.dld.2014.06.012] [Reference Citation Analysis]
69 Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2013;21:548-556. [PMID: 24240131 DOI: 10.1097/moo.0b013e3283658edf] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Savarino E, De Cassan C, Bodini G, Furnari M, de Bortoli N, Savarino V. The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol 2014;49:1362-3. [PMID: 24972668 DOI: 10.1007/s00535-014-0974-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Zerbib F, Sifrim D, Tutuian R, Attwood S, Lundell L. Modern medical and surgical management of difficult-to-treat GORD. United European Gastroenterol J 2013;1:21-31. [PMID: 24917938 DOI: 10.1177/2050640612473964] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
72 Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J 2013;1:175-83. [PMID: 24917957 DOI: 10.1177/2050640613485238] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
73 Martinucci I, Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 2014; 5(2): 86-96 [PMID: 24868489 DOI: 10.4292/wjgpt.v5.i2.86] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
74 Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G;  European Association of Endoscopic Surgery (EAES). EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-1773. [PMID: 24789125 DOI: 10.1007/s00464-014-3431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
75 Woodland P, Sifrim D. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors. Curr Opin Gastroenterol. 2013;29:431-436. [PMID: 23549342 DOI: 10.1097/mog.0b013e328360433c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
76 Savarino E, Zentilin P, Furnari M, Bodini G, Marabotto E, Savarino V. Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. J Neurogastroenterol Motil 2014;20:129-30. [PMID: 24466456 DOI: 10.5056/jnm.2014.20.1.129] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Martinucci I, de Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A, Savarino V, Frazzoni M, Marchi S. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26:546-555. [PMID: 24433456 DOI: 10.1111/nmo.12299] [Cited by in Crossref: 122] [Cited by in F6Publishing: 101] [Article Influence: 15.3] [Reference Citation Analysis]
78 DeVault K, McMahon BP, Celebi A, Costamagna G, Marchese M, Clarke JO, Hejazi RA, McCallum RW, Savarino V, Zentilin P. Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett’s esophagus. Ann N Y Acad Sci. 2013;1300:278-295. [PMID: 24117649 DOI: 10.1111/nyas.12253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
79 Furnari M, de Bortoli N, Savarino V, Marchi S, Savarino E. Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure. Surg Endosc. 2014;28:1382-1383. [PMID: 24162141 DOI: 10.1007/s00464-013-3291-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Savarino E, Zentilin P, Savarino V, Tenca A, Penagini R, Clarke JO, Bravi I, Zerbib F, Yüksel ES. Functional testing: pharyngeal pH monitoring and high-resolution manometry: Functional testing. Ann N Y Acad Sci 2013;1300:226-35. [DOI: 10.1111/nyas.12255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
81 de Bortoli N, Martinucci I, Marchi S, Savarino E. Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach. Surg Endosc 2014;28:698-9. [PMID: 23996339 DOI: 10.1007/s00464-013-3174-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Savarino E, Giacchino M, Savarino V. The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. Surg Endosc 2013;27:3503-4. [PMID: 23846361 DOI: 10.1007/s00464-013-3039-8] [Reference Citation Analysis]
83 Lee H, Lee SK, Park JC, Shin SK, Lee YC. Effect of acid swallowing on esophageal contraction in patients with heartburn related to hypersensitivity. J Gastroenterol Hepatol 2013;28:84-9. [PMID: 22988979 DOI: 10.1111/j.1440-1746.2012.07258.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 de Bortoli N, Martinucci I, Giacchino M, Blandizzi C, Marchi S, Savarino V, Savarino E. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol. 2013;9:1361-1369. [PMID: 23802731 DOI: 10.1517/17425255.2013.813018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
85 Park E, Choi M, Baeg M, Lim C, Kim J, Cho Y, Park J, Lee I, Kim S, Choi K. The Value of Early Wireless Esophageal pH Monitoring in Diagnosing Functional Heartburn in Refractory Gastroesophageal Reflux Disease. Dig Dis Sci 2013;58:2933-9. [DOI: 10.1007/s10620-013-2728-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
86 Frazzoni M, Piccoli M, Conigliaro R, Manta R, Frazzoni L, Melotti G. Reply to "the importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing". Surg Endosc 2013;27:4403-5. [PMID: 23760944 DOI: 10.1007/s00464-013-3041-1] [Reference Citation Analysis]
87 Savarino E, Zentilin P, Martinato M, Savarino V. Nonerosive reflux disease and functional heartburn are clearly separate entities: . European Journal of Gastroenterology & Hepatology 2013;25:749-50. [DOI: 10.1097/meg.0b013e32835df280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Niu XP, Yu BP, Wang YD, Han Z, Liu SF, He CY, Zhang GZ, Wu WC. Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease. World J Gastroenterol 2013; 19(20): 3124-3129 [PMID: 23716993 DOI: 10.3748/wjg.v19.i20.3124] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
89 Yarandi SS, Christie J. Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome. Gastroenterol Res Pract. 2013;2013:351086. [PMID: 23762034 DOI: 10.1155/2013/351086] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
90 Savarino E, Zentilin P, Galeazzi F, Savarino V. Symptom association analysis is important in GERD patients undergoing endoscopic therapy. Gastrointest Endosc 2013;77:832. [PMID: 23582538 DOI: 10.1016/j.gie.2012.11.037] [Reference Citation Analysis]
91 Savarino E, Giacchino M, Brunacci M, Savarino V. Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". Dig Liver Dis 2013;45:868-9. [PMID: 23583546 DOI: 10.1016/j.dld.2013.03.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Savarino E, de Bortoli N, Brunacci M, Savarino V. Letter: symptom indexes in reflux monitoring - two are better than one. Aliment Pharmacol Ther 2013;37:918. [PMID: 23551159 DOI: 10.1111/apt.12276] [Reference Citation Analysis]
93 Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-80. [DOI: 10.1038/nrgastro.2013.50] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 15.6] [Reference Citation Analysis]
94 Surdea Blaga T, Dumitrascu D, Galmiche J, Bruley des Varannes S. Functional heartburn: clinical characteristics and outcome. European Journal of Gastroenterology & Hepatology 2013;25:282-90. [DOI: 10.1097/meg.0b013e32835b108f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
95 Savarino E, Zentilin P, Savarino V. Esophageal acid exposure still plays a major role in patients with NERD. J Gastroenterol 2013;48:552-3. [DOI: 10.1007/s00535-013-0754-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Savarino E, Mei F, Parodi A, Ghio M, Furnari M, Gentile A, Berdini M, Di Sario A, Bendia E, Bonazzi P, Scarpellini E, Laterza L, Savarino V, Gasbarrini A. Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford). 2013;52:1095-1100. [PMID: 23382360 DOI: 10.1093/rheumatology/kes429] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
97 Woodland P, Lee C, Duraisamy Y, Farré R, Dettmar P, Sifrim D. Assessment and protection of esophageal mucosal integrity in patients with heartburn without esophagitis. Am J Gastroenterol. 2013;108:535-543. [PMID: 23358463 DOI: 10.1038/ajg.2012.469] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
98 Marelli S, Pace F. Rabeprazole for the treatment of acid-related disorders. Expert Rev Gastroenterol Hepatol. 2012;6:423-435. [PMID: 22928894 DOI: 10.1586/egh.12.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
99 Scarpignato C. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! Neurogastroenterol Motil. 2012;24:697-704. [PMID: 22783985 DOI: 10.1111/j.1365-2982.2012.01977.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
100 Savarino E, Zentilin P, Mastracci L, Dulbecco P, Marabotto E, Gemignani L, Bruzzone L, de Bortoli N, Frigo AC, Fiocca R. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol. 2013;48:473-482. [PMID: 23001252 DOI: 10.1007/s00535-012-0672-2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 11.3] [Reference Citation Analysis]
101 de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol 2012; 18(32): 4363-4370 [PMID: 22969200 DOI: 10.3748/wjg.v18.i32.4363] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 81] [Article Influence: 9.6] [Reference Citation Analysis]
102 Savarino E, de Bortoli N, Zentilin P, Martinucci I, Bruzzone L, Furnari M, Marchi S, Savarino V. Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol 2012; 18(32): 4371-4378 [PMID: 22969201 DOI: 10.3748/wjg.v18.i32.4371] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
103 Zerbib F, Bruley des Varannes S, Simon M, Galmiche JP. Functional heartburn: definition and management strategies. Curr Gastroenterol Rep. 2012;14:181-188. [PMID: 22451252 DOI: 10.1007/s11894-012-0255-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
104 Kessing BF, Smout AJ, Bredenoord AJ. Clinical applications of esophageal impedance monitoring and high-resolution manometry. Curr Gastroenterol Rep 2012;14:197-205. [PMID: 22350944 DOI: 10.1007/s11894-012-0253-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
105 Sung HJ, Cho YK, Moon SJ, Kim JS, Lim CH, Park JM, Lee IS, Kim SW, Choi MG. Role of Acid and weakly acidic reflux in gastroesophageal reflux disease off proton pump inhibitor therapy. J Neurogastroenterol Motil 2012;18:291-7. [PMID: 22837877 DOI: 10.5056/jnm.2012.18.3.291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
106 Savarino E, Zentilin P, Tutuian R, Pohl D, Gemignani L, Malesci A, Savarino V. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47:159-168. [PMID: 22038553 DOI: 10.1007/s00535-011-0480-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
107 Frazzoni M, Conigliaro R, Mirante VG, Melotti G. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141-146, e87. [PMID: 21988704 DOI: 10.1111/j.1365-2982.2011.01800.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
108 Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P. Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis. 2011;43:940-945. [PMID: 21944835 DOI: 10.1016/j.dld.2011.07.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
109 Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476-486. [PMID: 21671968 DOI: 10.1111/j.1365-2036.2011.04742.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 12.2] [Reference Citation Analysis]